(CIX: WRAL30)  1,120.31  up arrow+16.1  (1.46 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Apple)  110.99  up arrow+0.61  (0.55 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NY: QUINTILES)  70.61  down arrow-0.72  (-1.01 %)  Updated: 02:32 PM EDT, Oct 05 2015
(OP: BASF SE)  77.11  up arrow+1.32  (1.74 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: BioCryst)  12.40  down arrow-0.04  (-0.32 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: BioDelivery)  6.01  up arrow+0.11  (1.86 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: CEMP)  31.46  down arrow-0.32  (-0.99 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Cisco)  26.97  up arrow+1.21  (4.68 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Cree)  25.03  up arrow+0.63  (2.56 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: DARA)  0.87  up arrow+0.01  (1.6 %)  Updated: 02:31 PM EDT, Oct 05 2015
(NY: EMC)  25.23  up arrow+0.54  (2.19 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Extreme Networks)  3.48  up arrow+0.01  (0.14 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Facebook)  94.15  up arrow+2.08  (2.26 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NY: GLAXOSMITHKLINE)  39.91  up arrow+0.41  (1.04 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NQ: GOOG)  642.43  up arrow+15.52  (2.48 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NY: IBM)  149.26  up arrow+4.68  (3.24 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NY: LH)  113.13  up arrow+0.84  (0.75 %)  Updated: 02:32 PM EDT, Oct 05 2015
(OP: Lenovo Group)  17.72  up arrow+0.27  (1.55 %)  Updated: 01:40 PM EDT, Oct 05 2015
(NY: MRK)  51.15  up arrow+1.01  (2.01 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: Microsoft)  46.82  up arrow+1.25  (2.74 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NQ: NetApp)  30.81  up arrow+0.88  (2.94 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NY: NOVARTIS AG)  94.35  up arrow+1.08  (1.16 %)  Updated: 02:32 PM EDT, Oct 05 2015
(OP: Novozymes A/S)  43.89  up arrow+1.23  (2.88 %)  Updated: 02:13 PM EDT, Oct 05 2015
(NY: Pfizer)  33.17  up arrow+0.09  (0.26 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NQ: Pozen)  5.99  down arrow-0.29  (-4.62 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NY: Red Hat)  74.01  up arrow+0.39  (0.53 %)  Updated: 02:32 PM EDT, Oct 05 2015
(NQ: BBRY)  6.59  up arrow+0.25  (3.86 %)  Updated: 02:33 PM EDT, Oct 05 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  11.03  up arrow+0.52  (4.95 %)  Updated: 02:32 PM EDT, Oct 05 2015

Posts tagged “Quintiles”

March 26

Premium Lock Forbes: Quintiles, SAS, Citrix, Google, UNC Health among top employers

Forbes  In a survey of 20,000 American workers, several technology and life science companies as well as other employers with strong North Carolina connections crack the top ranks of "Forbes' "America's Best Employers" list. Among them: Quintiles, SAS, Citrix, Google, Apple as well as three health systems and two universities.

March 6

Premium Lock The Dennis Gillings's insider guide to entrepreneurship

Dennis Gillings Quintiles' co-founder and chairman Dennis Gillings looks back at his career and offers his insight about innovation to come. "If you're excited about the opportunity, you can make other people excited about it too," he says. "Excitement inspires people to give their best. It also makes life fun."

Updated February 25

Premium Lock Reddit, Google crack down on nude photos; GSK-Novartis deal nears close; Apple loses $539.M dispute; INC's first results; honor for Quintiles

Bulldog Bulletin In today's Bulldog wrapup of technology and life science news: Reddit and Google are cracking down on nude photos; GSK says Novartis deal nears close; Apple loses a big patent verdict; INC reports results; an honor for Quintiles.

February 24

Premium Lock Bronto's upbeat update; IBM targets hybrid cloud; Quintiles' new exec; YouTube for Kids half-baked?; Comcast earnings

In today's Bulldog wrapup of technology and life science news: Bronto's CEO offers a 2014 review via YouTube; IBM targets hybrid cloud; Quintiles adds a new exec; VentureBeat writer criticizes new YouTube for Kids; and Comcast income rises.

Updated February 19

Premium Lock Quintiles is No. 3 Fortune 'Most Admired' healthcare firm; IBM, AT&T crack overall top 50 with Apple No. 1

Fortune Quintiles, the world's largest life science services company, ranks No. 3 among industry rankings for healthcare pharmacy and other services in Fortune's annual "Most Admired" companies list. Apple is ranked No. 1 overall followed by Google. IBM and AT&T crack the top 50.

February 12

Premium Lock Quintiles CFO warns: More restructuring - i.e. layoffs - coming

Quintiles' headquarters       Quintiles delivered a quarterly financial report Thursday that topped Wall Street expectations, but in a conference call Chief Financial Officer Kevin Gordon warned that "restructuring" is coming. This will be the third consecutive year that Quintiles has cut some jobs even as it looks to fill some 1,200 positions and increased its headcount by some 3,000 in 2014.

February 12

Premium Lock CEO of Quintiles the giant to smaller CROs: 'I just don't know how they can compete ...'

Tom Pike Tom Pike, CEO of Quintiles which is the world's largest life sciences company and is looking to grow even bigger in 2015, believes small contract research organizations are in trouble. In a conference call, he predicts larger CROs will continue to 'capture share."

February 12

Premium Lock Quintiles' quarter beats Street on revenue, earnings

Quintiles            Quintiles beats Wall Street expectations in revenue and earnings with income topping $1.41 billion and profits of 69 cents per share. Plus, the world's largest life sciences services company projects growth of up to 16 percent per share in 2015.

February 10

Premium Lock NFL signs 5-year deal with Quintiles to study injuries, trends

Quintiles            The National Football League has signed a new five-year contract with Quintiles, the world's largest life sciences services company, to analyze player injuries and trends.

February 6

Premium Lock Quintiles founder Gillings to step down as chairman

Dennis Gillings, who co-founded Quintiles while he was a professor at UNC-Chapel Hill, plans to step down as the firm's chairman later this year. He will, however, remain a member of the board and "continue his close association" with the firm, Quintiles says.

Dennis Gillings, center, rings in NYSE actio Dennis Gillings, center, rings in NYSE actio

Updated December 9, 2014

Premium Lock NC firms help lead Ebola fight but face multiple battles

Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.

GSK's Donna Altenpohl GSK's Donna Altenpohl

Updated December 4, 2014

Premium Lock Quintiles wins top CRO award, topping INC Research, PPD

Quintiles            Quintiles is named the top contract research organization for the third straight year in the prestigious annual SCRIP Awards. The SCRIP Awards are among the best-known in the life science industry, so much so that three N.C. firms are major sponsors. Check out the entire list of winners.

December 1, 2014

Premium Lock Quintiles' new service package; Intel's buy; Samsung exec stays; BlackBerry's encryption deal; EU pressures Google

Bulldog In today's Bulldog wrapup of life science and technology news: Quintiles bundles a series of services for drug firms; Intel buys PasswordBox; Samsung keeps mobile business chief; BlackBerry signs encryption deal with Germany; and the EU steps up pressure on Google.

Updated November 14, 2014

Premium Lock Report: Clinical trials for new drugs need more diversity in participants

A new report says 895 clinical trials for new drugs targeting a wide variety of diseases are underway in North Carolina. But the "Research in Your Backyard" report says greater diversity in races, ages, sex and sexual orientation are needed.

Clinical trials underway in N.C. Clinical trials underway in N.C.

November 10, 2014

Premium Lock Quintiles, Metabolon CEOs headline CED biotech conference; diversity in emojis?; AT&T hiring in Triangle; AT&T's big buy; YouTube amends copyright

Bulldog In today's Bulldog wrapup of technology and life science news: The CEO of Quintiles along with the CEO of Metabolon headline the CED's biotech conference; Those emojis you like to use may soon come in colors; AT&T is hiring in Raleigh; AT&T making a big buy in Mexico; and YouTube amends copyright form.

November 5, 2014

Premium Lock Quintiles buying $250M in shares; investors selling 13 million

Quintiles            Founder Dennis Gillings and other key investors are selling 13 million shares in Quintiles, and the world's largest life science services firm is buying $250 million of them through an underwriter. The deal means Quintiles' big investors now own less than 50 percent of the company and some changes in governance are coming as a result, a spokesperson says.

Updated October 31, 2014

Premium Lock CEO: Look for Quintiles to take more firms 'under our wing'

Quintiles CEO Tom Pike is on the lookout for more acquisitions. In a quarterly earnings conference call Thursday, Pike said the world's largest life science services company is on the "lookout" to put acquisition targets "under our wing." Our Insider subscribers get the details.

Tom Pike Tom Pike

October 30, 2014

Premium Lock Quintiles beats Street, ups its earnings forecast

Quintiles            Quintiles meets Wall Street expectations for revenues but tops those same forecasts in earnings by a penny a share. The global life science services firm also ups its earnings forecast.

Updated October 9, 2014

Premium Lock Quintiles exec: Reduce clinical trial timelines to speed up drug, vaccine development

In the midst of the deadly Ebola outbreak and the rushing to trial of experimental treatments, the world's top life sciences services company is calling for faster drug and vaccine development. In a 21st Century Cures Initiative discussion hosted by Rep. Renee Ellmers on Thursday, the head of the Phase 1 Clinical Research Division at Quintiles, said Phase 1 trial "timelines" should be reduced by "addressing inefficiencies and redundancies." Quintiles has helped develop and commercialize all of the world's top 100 selling drugs in 2013.

Developing vaccines Developing vaccines

Updated October 6, 2014

Premium Lock Quintiles shutting down its continuing education business

Quintiles            Quintiles, the world's largest life science services company, is closing down its medical education business, the company tells WRAL TechWire, as part of a reorganization.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith